Eva Maria Dobrindt
Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin
Papers
2
Total Citations
22
H-Index
2
About
Eva Maria Dobrindt is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment, particularly through robotic-assisted surgery. Her major contributions center on demonstrating the safety, efficacy, and cost-equivalence of robotic-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE). In her highly cited 2023 study, she established that RAMIE is not only safe but also cost equivalent in a tertiary referral center, addressing a key barrier to broader adoption. Her 2024 work further revolutionized the field by showing that achieving "textbook outcome" after robotic and laparoscopic Ivor Lewis esophagectomy is significantly associated with improved disease-free and overall survival, providing a critical benchmark for surgical quality. With over 20 citations across her most impactful papers, Dobrindt’s research has directly influenced perioperative protocols and patient selection criteria. Her work at the intersection of surgical innovation and outcomes research positions her as a pivotal figure in esophageal oncology, helping to establish robotic surgery as a standard of care while proving that advanced technology can be both clinically superior and economically viable.
Research Focus
Key Achievements
Top Papers
- 1
- 2